Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Novel Non-Invasive Liver Fibrosis Tests Are Effective Biopsy Alternatives
February 2026
Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.
Read more
22 Sep 2017
Liver Disease: A Potential Protective Treatment Opportunity
PROTECTION against alcoholic liver disease may become possible thanks to new research surrounding the protein fibroblast growth factor 21 (FGF21). A…
22 Sep 2017
New Therapeutic Target for Liver Cancer Revealed
PIONEERING research from the University of Maryland, Baltimore, Maryland, USA, has found a potential link between a relatively under-studied gene and…
6 Sep 2017
Congenica’s Sapientia™ Selected by Coimbra Paediatric Hospital for Portugal’s In2Genome Genetic Disease Diagnosis Project
Cambridge, UK, 06 September, 2017 – Congenica, a global provider of clinical genomics interpretation software, today announced a new customer partnership…
26 Jun 2017
Alcoholic Liver Disease Aggravated by Intestinal Fungi
OVERGROWTH of intestinal fungi may exacerbate alcoholic liver disease (ALD), suggests a new study by researchers at the University of California, San…
26 Jun 2017
Stool Analysis: Non-Invasive Diagnostic Opportunities for Fatty Liver Disease
MICROBIAL patterns within stool samples may present a new method of diagnosis for nonalcoholic fatty liver disease (NAFLD), suggests a preliminary study…
8 Jun 2017
Introducing EMJ Hepatology 5.1
United Kingdom, June 08, 2017: Welcome to the latest edition of our EMJ Hepatology eJournal! This issue is jam-packed with the latest hepatological…
21
Mins
8 Jun 2017
Review of the 52nd International Liver Congress™ 2017
The diverse city of Amsterdam, Netherlands, hosted this year’s International Liver CongressTM (ILC) of the European Association for the Study of the Liver…
2
Mins
8 Jun 2017
The Importance of Civil Society Involvement in Eliminating Hepatitis C
This is an historic moment for hepatitis C treatment. With the advent of direct-acting antivirals (DAAs), we can now massively reduce the harm from an…
Loading posts...
« Previous
1
…
59
60
61
62
63
…
76
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View